15 Results for "

17β-HSD1

" in MedChemExpress (MCE) Product Catalog:
Products (15)

15 Results for "17β-HSD1" in MCE Product Catalog:

Cat. No.: HY-145433
CAS No.: 2760791-96-4
Purity:  99.34%
Target:  

17β-HSD

Research Areas:  

Cancer

17β-HSD1-IN-1 (Compound 1) is a highly selective 17β-HSD1 inhibitor with IC50s of 5.6 and 3155 nM for 17β-HSD1 and 17β-HSD2, respectively. 17β-HSD1-IN-1 can be used for the research of non-small cell lung cancer (NSCLC) .
loading...
    loading...
Cat. No.: HY-18173
CAS No.: 1048668-70-7
Target:  

11β-HSD

Research Areas:  

Metabolic Disease

AZD8329 is a potent 11β-Hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitor with an IC50 of 9 nM for human 11β-HSD1, displays excellent selectivity versus 11β-HSD2, 17β-HSD1 and 17β-HSD3 .
loading...
    loading...
Cat. No.: HY-129433
CAS No.: 1318265-18-7
Target:  

17β-HSD

Research Areas:  

Endocrinology

17β-HSD1-IN-2 (PBRM) is a non-estrogenic and steroidal covalent irreversible inhibitor of 17β-Hydroxysteroid dehydrogenase type 1 (17β-HSD1) (Ki=368 nM). 17β-HSD1-IN-2 can be used for the research of estrogen-dependent disorders .
loading...
    loading...
Cat. No.: HY-W002734
CAS No.: 87199-18-6
Synonyms: 3-Hydroxybenzeneboronic acid
Target:  

Drug Intermediate

Research Areas:  

Metabolic Disease

(3-Hydroxyphenyl)boronic acid (3-Hydroxybenzeneboronic acid) is a drug intermediate that can be used for the synthesis of 17β-hydroxysteroid dehydrogenase type 1 inhibitors .
loading...
    loading...
Cat. No.: HY-155010
CAS No.: 3033655-07-8
Target:  

Steroid Sulfatase

Research Areas:  

Metabolic Disease

Steroid sulfatase/17β-HSD1-IN-5 is a irreversible inhibitor of steroid sulfatase (STS) .Steroid sulfatase/17β-HSD1-IN-5 is a reversible and selective inhibitor of 7β-hydroxysteroid dehydrogenase type1 (17β-HSD1), with IC50s of 43 nM and 6.2μM for 17β-HSD1 and 17β-HSD2, respectively. Steroid sulfatase/17β-HSD1-IN-5 can be used for metabolic disease (especially for endometriosis) research .
loading...
    loading...
Cat. No.: HY-151199
CAS No.: 2990549-70-5
Target:  

Steroid Sulfatase

Research Areas:  

Endocrinology Cancer

Steroid sulfatase/17β-HSD1-IN-1 is a potent steroid sulfatase and 17β-hydroxysteroid dehydrogenase type 1 (17β-HSD1) inhibitor with an IC50 value of 28 nM for cellular human steroid sulfatase. Steroid sulfatase/17β-HSD1-IN-1 can be used to research estrogen-dependent diseases .
loading...
    loading...
Cat. No.: HY-W005186
CAS No.: 19063-55-9
Synonyms: 6-Bromochromen-2-one
Target:  

17β-HSD

Research Areas:  

Infection

6-Bromocoumarin (compound 34) is a potential anti-bacterial agent, with no inhibition against 17β-HSD1. 6-Bromocoumarin exhibtis affinity for α and β estrogen receptors .
loading...
    loading...
Cat. No.: HY-118382
CAS No.: 502628-66-2
Synonyms: STX1383
Target:  

17β-HSD

Research Areas:  

Cancer

SCH-451659 (STX1383) is an orally active, selective 17β-HSD3 inhibitor with an IC50 of 2.4 nM against h17β-HSD3. SCH-451659 selectively blocks the conversion of androstenedione to testosterone. SCH-451659 reduces testosterone levels in mice. SCH-451659 exhibits anticancer activity against androstenedione-dependent prostate tumors .
loading...
    loading...
Cat. No.: HY-151201
CAS No.: 2990549-76-1
Target:  

Steroid Sulfatase

Research Areas:  

Cancer

Steroid sulfatase/17β-HSD1-IN-3 (compound 19) is a dual inhibitor of steroid sulfatase (STS) and 17β-hydroxysteroid dehydrogenase type 1 (17β HSD1). Steroid sulfatase/17β-HSD1-IN-3 irreversibly inhibits hSTS activity with anIC50 value of 27 nM. Steroid sulfatase/17β-HSD1-IN-3 can be used in the study of endometriosis and other estrogen-dependent diseases .
loading...
    loading...
Cat. No.: HY-151202
CAS No.: 2990549-94-3
Target:  

Steroid Sulfatase

Research Areas:  

Cancer

Steroid sulfatase/17β-HSD1-IN-4 (compound 37) is a dual inhibitor of steroid sulfatase (STS) and 17β-hydroxysteroid dehydrogenase type 1 (17β HSD1). Steroid sulfatase/17β-HSD1-IN-4 irreversibly inhibits hSTS activity with anIC50 value of 63 nM. Steroid sulfatase/17β-HSD1-IN-4 can be used in the study of endometriosis and other estrogen-dependent diseases .
loading...
    loading...
Cat. No.: HY-W267205
CAS No.: 10441-27-7
Target:  

17β-HSD

Research Areas:  

Endocrinology Cancer

3-Acetyl-7-Hydroxycoumarin (Compound 2) is a high selective 17-beta-hydroxysteroid dehydrogenase type 1 (17β-HSD1) inhibitor. 3-Acetyl-7-Hydroxycoumarin shows a significant improvement of the inhibitory potency, with 57% inhibition of 17β-HSD1 at 6 μM. 3-Acetyl-7-Hydroxycoumarin is promising for research of hormone-dependent diseases, such as breast cancer and endometriosis .
loading...
    loading...
Cat. No.: HY-43322
CAS No.: 108530-10-5
Target:  

17β-HSD

Research Areas:  

Cancer

7-Coumaryl triflate is a type 17β-HSD1 inhibitor of 17β-hydroxysteroid dehydrogenase. Its IC50 is 360 nM and Ki is 173 nM. 7-Coumaryl triflate shows selectivity for 17β-HSD2 and has no detectable affinity for ERα or ERβ. 7-Coumaryl triflate can be used in related research on hormone-dependent breast cancer .
loading...
    loading...
Cat. No.: HY-151200
CAS No.: 2990549-73-8
Target:  

Steroid Sulfatase

Research Areas:  

Endocrinology

Steroid sulfatase-IN-4 (Compound 16) is an irreversible steroid sulfatase (STS) inhibitor with an IC50 of 25 nM against human STS. Steroid sulfatase-IN-4 can be used for the research of endometriosis .
loading...
    loading...
Cat. No.: HY-189008
Target:  

Others

17β-HSD13-IN-1 is a selective 17β-HSD13 inhibitor with a human IC50 of 9 nM, high selectivity over 17β-HSD1, nanomolar cellular activity, broad pH solubility, extended rodent plasma mean residence times, and high oral bioavailability in Mus musculus. 17β-HSD13-IN-1 engages in hydrophobic interactions with specific active-site amino acids of its target enzyme. 17β-HSD13-IN-1 can be used for the research of metabolic dysfunction-associated steatohepatitis (mash) .
loading...
    loading...
Cat. No.: HY-183905
CAS No.: 1401564-00-8
KR-67607 is a selective 11β-HSD1 inhibitor, with an IC50 value of 4.8 nM against h11β-HSD1 and 7.1 nM against mouse 11β-HSD1. KR-67607 inhibits stress-induced Glucocorticoid receptor nuclear translocation, reduces cortisol levels, suppresses the expression of ROS and proinflammatory cytokines, and enhances Nrf-2-mediated antioxidant gene transcription. KR-67607 maintains trabecular meshwork structure and reverses elevated intraocular pressure. KR-67607 improves ocular antioxidant activity and mucus secretion, reverses ocular surface damage, and prevents ischemia-reperfusion induced ocular injury. KR-67607 can be used in research related to glaucoma and dry eye disease .
loading...
    loading...
  • 1